Pricing
Login
Home
Charts
Search
Watchlist
Products

Gland Pharma Ltd

GLAND
₹3,331.90+1.18%20 Nov 2026
Reports
Pharma Formulations

Gland Pharma Ltd

GLAND
₹3,331.90
+1.18%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹54,981Cr
Close
Close Price
₹3,331.90
Industry
Industry
Pharma Formulations
PE
Price To Earnings
44.44
PS
Price To Sales
7.77
Revenue
Revenue
₹7,072Cr
Rev Gr TTM
Revenue Growth TTM
21.90%
PAT Gr TTM
PAT Growth TTM
56.36%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,5451,5371,4021,4061,3841,4251,5061,4871,6951,7431,8001,834
Growth YoY
Revenue Growth YoY%
64.795.816.02.4-10.4-7.37.45.822.522.319.623.3
Expenses
ExpensesCr
1,1891,1791,1371,1091,0241,0771,1381,1731,2601,2301,3111,350
Operating Profit
Operating ProfitCr
356359264297360348368314435513489484
OPM
OPM%
23.123.318.921.126.024.424.421.125.629.427.226.4
Other Income
Other IncomeCr
3742516058445884391116169
Interest Expense
Interest ExpenseCr
5106623712841047
Depreciation
DepreciationCr
1059392949696101106108109111115
PBT
PBTCr
283298218257299288313284362506435431
Tax
TaxCr
9110674939510297100101139118140
PAT
PATCr
192192144164205187215184261367317291
Growth YoY
PAT Growth YoY%
-17.3144.6-25.9-15.76.7-3.149.912.327.796.647.158.3
NPM
NPM%
12.412.510.311.614.813.114.312.315.421.017.615.9
EPS
EPS₹
11.711.78.79.912.411.313.111.215.922.319.217.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,5451,5371,4021,4061,3841,4251,5061,4871,6951,7431,8001,834
Growth YoY
Revenue Growth YoY%
64.795.816.02.4-10.4-7.37.45.822.522.319.623.3
Expenses
ExpensesCr
1,1891,1791,1371,1091,0241,0771,1381,1731,2601,2301,3111,350
Operating Profit
Operating ProfitCr
356359264297360348368314435513489484
OPM
OPM%
23.123.318.921.126.024.424.421.125.629.427.226.4
Other Income
Other IncomeCr
3742516058445884391116169
Interest Expense
Interest ExpenseCr
5106623712841047
Depreciation
DepreciationCr
1059392949696101106108109111115
PBT
PBTCr
283298218257299288313284362506435431
Tax
TaxCr
9110674939510297100101139118140
PAT
PATCr
192192144164205187215184261367317291
Growth YoY
PAT Growth YoY%
-17.3144.6-25.9-15.76.7-3.149.912.327.796.647.158.3
NPM
NPM%
12.412.510.311.614.813.114.312.315.421.017.615.9
EPS
EPS₹
11.711.78.79.912.411.313.111.215.922.319.217.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,6333,4634,4013,6255,6655,6176,4317,072
Growth
Revenue Growth%
31.527.1-17.656.3-0.814.521.9
Expenses
ExpensesCr
1,6782,1612,8912,6004,3324,3484,8015,151
Operating Profit
Operating ProfitCr
9551,3021,5101,0251,3331,2691,6301,921
OPM
OPM%
36.337.634.328.323.522.625.327.2
Other Income
Other IncomeCr
139135224184170214292281
Interest Expense
Interest ExpenseCr
735726423325
Depreciation
DepreciationCr
9599110147345378424443
PBT
PBTCr
9931,3351,6191,0551,1331,0631,4651,734
Tax
TaxCr
220338407274360364437498
PAT
PATCr
7739971,2127817726991,0271,236
Growth
PAT Growth%
29.021.5-35.5-1.1-9.647.156.4
NPM
NPM%
29.428.827.521.613.612.416.017.5
EPS
EPS₹
49.963.173.847.446.942.462.475.0
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,6333,4634,4013,6255,6655,6176,4317,072
Growth
Revenue Growth%
31.527.1-17.656.3-0.814.521.9
Expenses
ExpensesCr
1,6782,1612,8912,6004,3324,3484,8015,151
Operating Profit
Operating ProfitCr
9551,3021,5101,0251,3331,2691,6301,921
OPM
OPM%
36.337.634.328.323.522.625.327.2
Other Income
Other IncomeCr
139135224184170214292281
Interest Expense
Interest ExpenseCr
735726423325
Depreciation
DepreciationCr
9599110147345378424443
PBT
PBTCr
9931,3351,6191,0551,1331,0631,4651,734
Tax
TaxCr
220338407274360364437498
PAT
PATCr
7739971,2127817726991,0271,236
Growth
PAT Growth%
29.021.5-35.5-1.1-9.647.156.4
NPM
NPM%
29.428.827.521.613.612.416.017.5
EPS
EPS₹
49.963.173.847.446.942.462.475.0
Sales CAGR
1 Year14%
3 Years21%
5 Years13%
TTM22%
EBITDA CAGR
1 Year28%
3 Years17%
5 Years5%
TTM38%
PAT CAGR
1 Year47%
3 Years10%
5 Years1%
TTM56%
Avg. ROCE
1 Year14%
3 Years13%
5 Years15%
TTM16%
CFO / EBITDA
1 Year63%
3 Years70%
5 Years61%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
1616161616161617
Reserves
ReservesCr
3,6315,8877,1417,9428,7079,13410,34110,669
Current Liabilities
Current LiabilitiesCr
3595135827291,3981,5651,6081,714
Non Current Liabilities
Non Current LiabilitiesCr
81809490539509545527
Total Liabilities
Total LiabilitiesCr
4,0866,4967,8348,77810,66111,22512,51112,927
Current Assets
Current AssetsCr
2,8465,1245,8526,9015,6456,7837,5277,872
Non Current Assets
Non Current AssetsCr
1,2401,3721,9821,8775,0164,4424,9845,054
Total Assets
Total AssetsCr
4,0866,4967,8348,77810,66111,22512,51112,927
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
1616161616161617
Reserves
ReservesCr
3,6315,8877,1417,9428,7079,13410,34110,669
Current Liabilities
Current LiabilitiesCr
3595135827291,3981,5651,6081,714
Non Current Liabilities
Non Current LiabilitiesCr
81809490539509545527
Total Liabilities
Total LiabilitiesCr
4,0866,4967,8348,77810,66111,22512,51112,927
Current Assets
Current AssetsCr
2,8465,1245,8526,9015,6456,7837,5277,872
Non Current Assets
Non Current AssetsCr
1,2401,3721,9821,8775,0164,4424,9845,054
Total Assets
Total AssetsCr
4,0866,4967,8348,77810,66111,22512,51112,927

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7016057913649979151,031
Investing Cash Flow
Investing Cash FlowCr
-766-1,524-1,0031,208-1,7571,705138
Financing Cash Flow
Financing Cash FlowCr
-71,2383515-799-433-417
Net Cash Flow
Net Cash FlowCr
-72319-1771,587-1,5602,186752
Free Cash Flow
Free Cash FlowCr
530377280143608531541
CFO To PAT
CFO To PAT%
90.760.765.346.6129.0130.9100.4
CFO To EBITDA
CFO To EBITDA%
73.446.552.435.574.872.163.3
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7016057913649979151,031
Investing Cash Flow
Investing Cash FlowCr
-766-1,524-1,0031,208-1,7571,705138
Financing Cash Flow
Financing Cash FlowCr
-71,2383515-799-433-417
Net Cash Flow
Net Cash FlowCr
-72319-1771,587-1,5602,186752
Free Cash Flow
Free Cash FlowCr
530377280143608531541
CFO To PAT
CFO To PAT%
90.760.765.346.6129.0130.9100.4
CFO To EBITDA
CFO To EBITDA%
73.446.552.435.574.872.163.3

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40,53553,71320,89430,33826,23327,96454,981
Price To Earnings
Price To Earnings
40.744.326.839.337.527.244.4
Price To Sales
Price To Sales
11.712.25.85.44.74.37.8
Price To Book
Price To Book
6.97.52.63.52.92.75.2
EV To EBITDA
EV To EBITDA
28.833.516.721.718.915.327.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.351.046.845.852.453.656.556.5
OPM
OPM%
36.337.634.328.323.522.625.327.2
NPM
NPM%
29.428.827.521.613.612.416.017.5
ROCE
ROCE%
27.422.622.713.312.711.714.116.1
ROE
ROE%
21.216.916.99.88.87.69.911.6
ROA
ROA%
18.915.315.58.97.36.28.29.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40,53553,71320,89430,33826,23327,96454,981
Price To Earnings
Price To Earnings
40.744.326.839.337.527.244.4
Price To Sales
Price To Sales
11.712.25.85.44.74.37.8
Price To Book
Price To Book
6.97.52.63.52.92.75.2
EV To EBITDA
EV To EBITDA
28.833.516.721.718.915.327.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.351.046.845.852.453.656.556.5
OPM
OPM%
36.337.634.328.323.522.625.327.2
NPM
NPM%
29.428.827.521.613.612.416.017.5
ROCE
ROCE%
27.422.622.713.312.711.714.116.1
ROE
ROE%
21.216.916.99.88.87.69.911.6
ROA
ROA%
18.915.315.58.97.36.28.29.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr74,73361,99459,38654,98146,77844,35141,458
Close PriceClose₹2,648.005,185.00364.403,331.901,843.802,337.803,317.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE51.4929.98121.8744.4432.4640.5432.82
Price To SalesPS4.693.973.417.774.464.336.67
RevenueRevenueCr15,93715,63217,4157,07210,47910,2346,217
Revenue Growth TTMRev Gr TTM%-0.1%12.5%5.7%21.9%12.0%21.1%25.0%
PAT Growth TTMPAT Gr TTM%43.7%-13.2%-55.4%56.4%72.8%33.3%29.7%
Market CapitalizationMkt CapCr74,73361,99459,38654,98146,77844,35141,458
Close PriceClose₹2,648.005,185.00364.403,331.901,843.802,337.803,317.70
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE51.4929.98121.8744.4432.4640.5432.82
Price To SalesPS4.693.973.417.774.464.336.67
RevenueRevenueCr15,93715,63217,4157,07210,47910,2346,217
Revenue Growth TTMRev Gr TTM%-0.1%12.5%5.7%21.9%12.0%21.1%25.0%
PAT Growth TTMPAT Gr TTM%43.7%-13.2%-55.4%56.4%72.8%33.3%29.7%
Annual Reports
Quarterly Reports
FY
Annual Reports
Quarterly Reports
Interviews